← FDA Drug Approvals (Drugs@FDA)

IPRIVASK

BLA · Biologics License Application · Sponsor: BAUSCH · Approved 2003-04-04

Drug application

FDA Application #

BLA021271

Application type

Biologics License Application

Brand name

IPRIVASK

Generic name

Desirudin Recombinant

Active ingredients

DESIRUDIN RECOMBINANT

Dosage form

INJECTABLE

Route

SUBCUTANEOUS

Marketing status

Discontinued

Sponsor

BAUSCH

First approval

2003-04-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown